Jaguar Animal Health Inc (JAGX)

0.80
0.01 1.27
NASDAQ : Health Care
Prev Close 0.79
Open 0.81
Day Low/High 0.79 / 0.81
52 Wk Low/High 1.19 / 4.70
Volume 53.82K
Avg Volume 1.22M
Exchange NASDAQ
Shares Outstanding 14.42M
Market Cap 11.40M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Jaguar Animal Health Stock Rises on Napo Pharma Merger

Jaguar Animal Health Stock Rises on Napo Pharma Merger

Jaguar Animal Health (JAGX) stock was surging by 20% to $1.14 on Friday morning

Jaguar Animal Health Stock Skyrocketing on Napo Pharma Merger

Jaguar Animal Health Stock Skyrocketing on Napo Pharma Merger

Jaguar Animal Health and Napo Pharmaceuticals have signed a merger agreement.

Jaguar Animal Health And Napo Pharmaceuticals Enter Definitive Merger Agreement

Jaguar Animal Health And Napo Pharmaceuticals Enter Definitive Merger Agreement

Napo Pharmaceuticals, Inc. ("Napo"), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and Jaguar Animal Health, Inc.

Jaguar Enters Exclusive Evaluation Period With Multinational Animal Health Pharmaceutical Firm Regarding Equilevia, Jaguar's Drug Product Candidate For Equine Gastric Ulcer Syndrome

Jaguar Enters Exclusive Evaluation Period With Multinational Animal Health Pharmaceutical Firm Regarding Equilevia, Jaguar's Drug Product Candidate For Equine Gastric Ulcer Syndrome

Jaguar Animal Health, Inc. (NASDAQ: JAGX) (Jaguar), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Seeks MUMS Designation For Canalevia For Exercise-Induced Diarrhea In Dogs

Jaguar Animal Health Seeks MUMS Designation For Canalevia For Exercise-Induced Diarrhea In Dogs

Jaguar Animal Health, Inc. (NASDAQ:JAGX) (Jaguar), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health To Participate In 29th Annual ROTH Conference The Week Of March 13th In Orange County, California

Jaguar Animal Health To Participate In 29th Annual ROTH Conference The Week Of March 13th In Orange County, California

Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Study Supporting Herd-wide Reduction In Incidence And Severity Of Diarrhea With Prophylactic Use Of Neonorm Calf Published In Journal Of Dairy Science

Study Supporting Herd-wide Reduction In Incidence And Severity Of Diarrhea With Prophylactic Use Of Neonorm Calf Published In Journal Of Dairy Science

Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

These 5 Stocks Under $10 Could Explode Up Soon

These 5 Stocks Under $10 Could Explode Up Soon

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

Jaguar Animal Health Enters Binding Agreement Of Terms To Merge With Napo Pharmaceuticals

Jaguar Animal Health Enters Binding Agreement Of Terms To Merge With Napo Pharmaceuticals

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Begins Entry Into Organic Market With Neonorm Calf

Jaguar Animal Health Begins Entry Into Organic Market With Neonorm Calf

Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health, Elanco Enter Global Collaboration For Development, Co-Promotion Of Canalevia

Jaguar Animal Health, Elanco Enter Global Collaboration For Development, Co-Promotion Of Canalevia

Jaguar Animal Health, Inc. (NASDAQ: JAGX) and Elanco US Inc.

Jaguar Animal Health To Participate In Biotech Showcase 2017 Week Of January 9th In San Francisco

Jaguar Animal Health To Participate In Biotech Showcase 2017 Week Of January 9th In San Francisco

Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Napo Pharmaceuticals Secures $2 Million In Financing

Napo Pharmaceuticals Secures $2 Million In Financing

Napo Pharmaceuticals, Inc. ("Napo"), announced today that it has obtained $2 million in secured convertible debt financing from New York-based Kingdon Capital Management, LLC.

Jaguar Animal Health Appoints Dr. Ari Azhir To Board Of Directors

Jaguar Animal Health Appoints Dr. Ari Azhir To Board Of Directors

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health And Henry Schein, Inc. Sign Exclusive Distribution Agreement For Neonorm Foal

Jaguar Animal Health And Henry Schein, Inc. Sign Exclusive Distribution Agreement For Neonorm Foal

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Exhibits Neonorm Foal At American Association Of Equine Practitioners Annual Convention

Jaguar Animal Health Exhibits Neonorm Foal At American Association Of Equine Practitioners Annual Convention

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Announces Private Placement Of Common Stock And Warrants

Jaguar Animal Health Announces Private Placement Of Common Stock And Warrants

Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Issues Racing Data Summary For Horses Participating In The Company's Recently Completed Dose Determination Study For Its Drug Product Candidate For Equine Gastric Ulcer Syndrome

Jaguar Animal Health Issues Racing Data Summary For Horses Participating In The Company's Recently Completed Dose Determination Study For Its Drug Product Candidate For Equine Gastric Ulcer Syndrome

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Announces Final Topline Results For Proof-of-Concept Study For Secretory Diarrhea In Dogs

Jaguar Animal Health Announces Final Topline Results For Proof-of-Concept Study For Secretory Diarrhea In Dogs

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Napo Pharmaceuticals Launches Mytesi (crofelemer) As The Only FDA-Approved Treatment For Relief Of Noninfectious Diarrhea In HIV+ Patients

Napo Pharmaceuticals Launches Mytesi (crofelemer) As The Only FDA-Approved Treatment For Relief Of Noninfectious Diarrhea In HIV+ Patients

Launch Includes Copay Savings and Patient Assistance Programs to Ensure Affordable Access to Mytesi™, Formerly Marketed as Fulyzaq®

Jaguar Animal Health And Napo Pharmaceuticals Announce Details For Proposed Merger

Jaguar Animal Health And Napo Pharmaceuticals Announce Details For Proposed Merger

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value...

Jaguar Animal Health Signs Exclusive Distribution Agreement For Croton Lechleri Botanical Extract For Pigs And Dairy Cattle In The Chinese Marketplace

Jaguar Animal Health Signs Exclusive Distribution Agreement For Croton Lechleri Botanical Extract For Pigs And Dairy Cattle In The Chinese Marketplace

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals,...

Jaguar Animal Health (JAGX) Stock Surges on Neonorm Calf Trial Success

Jaguar Animal Health (JAGX) Stock Surges on Neonorm Calf Trial Success

Jaguar Animal Health (JAGX) said today that its Neonorm Calf drug successfully met topline goals and that it's in the process of getting the drug distributed in China.

Jaguar Animal Health Announces Additional Topline Results From Study Of Second-Generation Formulation Of Neonorm Calf Conducted In Association With Cornell University College Of Veterinary Medicine

Jaguar Animal Health Announces Additional Topline Results From Study Of Second-Generation Formulation Of Neonorm Calf Conducted In Association With Cornell University College Of Veterinary Medicine

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals,...

Jaguar Animal Health Appoints Leading Oncologist And Drug Development Executive As Chief Scientific Officer

Jaguar Animal Health Appoints Leading Oncologist And Drug Development Executive As Chief Scientific Officer

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals,...

Jaguar Animal Health Announces Positive Topline Results Of University Study Of Second-Generation Formulation Of Neonorm Calf And Commercialization Strategy Updates

Jaguar Animal Health Announces Positive Topline Results Of University Study Of Second-Generation Formulation Of Neonorm Calf And Commercialization Strategy Updates

Jaguar Animal Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals,...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: NEWS, SSRI, TSE Downgrades: AL, BX, FINL, FLR, LYG, MAGS, RDY, STRT, TOT Initiations: ANTX, JAGX Read on to get TheStreet Quant Ratings' detailed report: